top of page
Search

UK Atropine Myopia Trial Recruiting — Practitioners Invited to Refer Suitable Patients

Clinical research is essential if we are to continue improving how childhood myopia is managed. A UK clinical trial investigating low-dose atropine for myopia control is currently recruiting participants, and practitioners may have suitable patients who could benefit from taking part.


If you have children in your practice who meet the criteria, please consider making families aware of this opportunity. Referring suitable patients helps advance the evidence base that will guide future myopia management.



















The MODERATO trial, sponsored by Ocus International, is a randomised controlled trial evaluating 0.025% and 0.05% atropine eye drops versus placebo for slowing myopia progression in children.


Recruitment sites in the UK include:


  • Aston University — Birmingham

  • Queen’s University Belfast — Belfast

  • Moorfields Eye Hospital — London


Practitioners with patients within travelling distance of these centres are encouraged to help raise awareness by directing interested families to the research team.


Study Parameters


Children may be eligible if they meet the following criteria:


  • Age: 3–17 years

  • Refraction: ≥ −0.75DS (no upper limit)

  • Astigmatism / anisometropia: ≤1.50D

  • Exclusion: no myopia control treatment within the previous 3 months

  • Vision correction: participants continue wearing their usual single-vision spectacles or contact lenses


Study Schedule


This is a two-year study with six visits:

  • Baseline

  • 3 months

  • 6 months

  • 12 months

  • 18 months

  • 24 months


An early escape option is available at 6 months if clinically appropriate.


How Practitioners Can Help

If you have suitable patients in your practice, please consider informing families about the trial and encouraging them to contact the research team to learn more about participation.



Further details about the trial are available here:https://www.ocus-inno.com/moderato-trial/

By helping connect eligible patients with clinical research, practitioners play an important role in advancing the evidence base for myopia management and improving care for future generations of children.

 
 
 

Comments

bottom of page